Compare RYOJ & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYOJ | NMTC |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8M | 29.2M |
| IPO Year | N/A | 2010 |
| Metric | RYOJ | NMTC |
|---|---|---|
| Price | $2.48 | $3.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.90 |
| AVG Volume (30 Days) | ★ 304.9K | 25.5K |
| Earning Date | 12-15-2025 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.90 |
| P/E Ratio | $19.04 | ★ N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $1.56 | $0.55 |
| 52 Week High | $11.43 | $5.40 |
| Indicator | RYOJ | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 44.89 | 41.27 |
| Support Level | $1.85 | $0.69 |
| Resistance Level | $2.53 | $4.87 |
| Average True Range (ATR) | 0.40 | 0.20 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 7.44 | 36.75 |
rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.